Sergio Campoy

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Journal: Cephalalgia : an international journal of headache

Published: June 19, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: May 27, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: January 28, 2026

Linear Accelerator Mask-Based Radiosurgery for Trigeminal Neuralgia: Prospective Evaluation of 50 Patients.

Linear Accelerator Mask-Based Radiosurgery for Trigeminal Neuralgia: Prospective Evaluation of 50 Patients.

Journal: World neurosurgery

Published: January 27, 2026

Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study.

Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study.

Journal: Headache

Published: September 06, 2025

Authors' response to comment on "Second-line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin, and baclofen".

Authors' response to comment on "Second-line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin, and baclofen".

Journal: Headache

Published: July 20, 2025

Concomitant anti-CGRP and immunomodulatory treatments in patients with migraine: towards integrated management strategies.

Concomitant anti-CGRP and immunomodulatory treatments in patients with migraine: towards integrated management strategies.

Journal: Journal of neurology

Published: March 31, 2025

Second-line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin and baclofen.

Second-line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin and baclofen.

Journal: Headache

Published: October 23, 2024

Visual snow syndrome in patients with migraine: widening the clinical spectrum of the syndrome with permanent and episodic manifestations.

Visual snow syndrome in patients with migraine: widening the clinical spectrum of the syndrome with permanent and episodic manifestations.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: January 22, 2024

Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.

Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: December 27, 2023

Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients.

Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients.

Journal: The journal of headache and pain

Published: February 09, 2023

Oral lacosamide for the treatment of refractory trigeminal neuralgia: A retrospective analysis of 86 cases.

Oral lacosamide for the treatment of refractory trigeminal neuralgia: A retrospective analysis of 86 cases.

Journal: Headache

Published: December 08, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026